|
WDR41 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.578300E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.791100E-04 |
| Normal-vs-Stage2 |
1.898560E-01 |
| Normal-vs-Stage3 |
1.080780E-01 |
| Normal-vs-Stage4 |
3.162800E-01 |
| Stage1-vs-Stage2 |
3.352200E-01 |
| Stage1-vs-Stage3 |
1.062620E-01 |
| Stage1-vs-Stage4 |
8.858200E-02 |
| Stage2-vs-Stage3 |
9.078800E-01 |
| Stage2-vs-Stage4 |
6.894400E-01 |
| Stage3-vs-Stage4 |
7.142200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.649550E-02 |
| Normal-vs-AfricanAmerican |
8.504600E-03 |
| Normal-vs-Asian |
9.797200E-03 |
| Caucasian-vs-AfricanAmerican |
2.794800E-01 |
| Caucasian-vs-Asian |
3.852200E-01 |
| AfricanAmerican-vs-Asian |
6.708000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.302200E-02 |
| Normal-vs-Female |
3.140200E-03 |
| Male-vs-Female |
6.962600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.462570E-03 |
| Normal-vs-Age(41-60Yrs) |
8.322100E-02 |
| Normal-vs-Age(61-80Yrs) |
2.518000E-02 |
| Normal-vs-Age(81-100Yrs) |
3.688200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.564400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.804600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.104200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.906800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.432200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.052000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.148400E-01 |
| Classical-VS-Follicular |
1.576750E-01 |
| Classical-VS-Other |
2.687000E-01 |
| Classical-VS-Normal |
5.223500E-04 |
| Tall-VS-Follicular |
7.893800E-01 |
| Tall-VS-Other |
6.253800E-01 |
| Tall-VS-Normal |
3.344600E-01 |
| Follicular-VS-Other |
5.681400E-01 |
| Follicular-VS-Normal |
1.353020E-01 |
| Other-VS-Normal |
9.899200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.944800E-03 |
| Normal-vs-N1 |
2.993000E-01 |
| N0-vs-N1 |
3.948800E-01 |
|
|
